Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4208)
All Articles published online
|
Sep 14, 2010 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Gao XZ, Qiao XL, Song WC, Wang XF, Liu F. Standard triple, bismuth pectin quadruple and sequential therapies for |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i34/4357.htm |
| Number | Citing Articles |
| 1 |
Olga P Nyssen, Adrian G McNicholl, Francis Megraud, Vincenzo Savarino, Giuseppina Oderda, Carlo A Fallone, Lori Fischbach, Franco Bazzoli, Javier P Gisbert. Sequential versus standard triple first-line therapy for Helicobacter pylori
eradication. Cochrane Database of Systematic Reviews 2016; 2016(6) doi: 10.1002/14651858.CD009034.pub2
|
| 2 |
J. P. Gisbert, X. Calvet. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori. Alimentary Pharmacology & Therapeutics 2011; 34(6): 604 doi: 10.1111/j.1365-2036.2011.04770.x
|
| 3 |
Jong In Kim, Byung-Wook Kim. Sequential Therapy ofHelicobacter pyloriInfection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2011; 11(2): 103 doi: 10.7704/kjhugr.2011.11.2.103
|
| 4 |
Anthony O’Connor, Javier P. Gisbert, Deirdre McNamara, Colm O’Morain. Treatment of Helicobacter pylori Infection 2011. Helicobacter 2011; 16(s1): 53 doi: 10.1111/j.1523-5378.2011.00881.x
|
| 5 |
Fariborz Mansour-Ghanaei, Behnam Masihipour, Mohammad Fathalipour, Soheil Hassanipour, Homayoon Sokhanvar, Alireza Mansour-Ghanaei, Mehrnaz Asgharnezhad, Farahnaz Joukar, Sandrina A. Heleno. The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Helicobacter pylori Eradication: A Randomized, Double-Blind Clinical Trial. Evidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/9794901
|
| 6 |
Sotirios D. Georgopoulos, Vasilios Papastergiou, Stylianos Karatapanis. Helicobacter pyloriEradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy. Gastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/757926
|
| 7 |
Liya Zhou, Hong Lu, Zhiqiang Song, Bin Lyu, Ye Chen, Jiyao Wang, Jun Xia, Zhan Zhao. 2022 Chinese national clinical practice guideline on Helicobacter pylori eradication treatment. Chinese Medical Journal 2022; 135(24): 2899 doi: 10.1097/CM9.0000000000002546
|
| 8 |
Ji Hyuk Kang, Yun Jeong Lim. Trend for Treatment ofHelicobacter pyloriin Overseas Country. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2012; 12(4): 224 doi: 10.7704/kjhugr.2012.12.4.224
|
| 9 |
Theodore Rokkas, Javier P. Gisbert, Peter Malfertheiner, Yaron Niv, Antonio Gasbarrini, Marcis Leja, Francis Megraud, Colm O’Morain, David Y. Graham. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis. Gastroenterology 2021; 161(2): 495 doi: 10.1053/j.gastro.2021.04.012
|
| 10 |
Mounia Lahbabi, Samia Alaoui, Karima El Rhazi, Mohammed El Abkari, Chakib Nejjari, Afaf Amarti, Bahia Bennani, Mustapha Mahmoud, Adil Ibrahimi, Dafr Allah Benajah. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: Result of the HPFEZ randomised study. Clinics and Research in Hepatology and Gastroenterology 2013; 37(4): 416 doi: 10.1016/j.clinre.2012.10.002
|
| 11 |
Xiao-Min Liao, Gao-Hui Nong, Mei-Zu Chen, Xue-Ping Huang, Yun-Yan Cong, Yi-Ying Huang, Bai-He Wu, Jin-Qi Wei. Modified sequential therapy <italic>vs</italic> quadruple therapy as initial therapy in patients with <italic>Helicobacter</italic> infection. World Journal of Gastroenterology 2015; 21(20): 6310-6316 doi: 10.3748/wjg.v21.i20.6310
|
| 12 |
Manas Kumar Panigrahi, Mohd Imran Chouhan, Vinay Kumar Hallur, Madhav Sameer Makashir, Chandan Kumar, Shivam Sethi, Hemanta Kumar Nayak, Biswa Mohan Padhy, Subash Chandra Samal. Comparison of the efficacies of triple, quadruple and sequential antibiotic therapy in eradicating Helicobacter pylori infection: A randomized controlled trial. Indian Journal of Gastroenterology 2023; 42(4): 517 doi: 10.1007/s12664-022-01322-8
|
| 13 |
Yasser Abu-Safieh, Hanin Yamin. Sequential and concomitant non-bismuth quadruple therapies are ineffective for <i>H. pylori</i> eradication in Palestine. A randomized trial. Open Journal of Gastroenterology 2012; 2(04): 177 doi: 10.4236/ojgas.2012.24034
|
| 14 |
Javier P. Gisbert. Optimization Strategies Aimed to Increase the Efficacy of Helicobacter pylori Eradication Therapies with Quinolones. Molecules 2020; 25(21): 5084 doi: 10.3390/molecules25215084
|
| 15 |
Youhua Wang, Ben Wang, Zhi Fa Lv, Yang Yang, Fucai Wang, Hui Wang, Shuping Chen, Yong Xie, Xiaojiang Zhou. Efficacy and Safety of Ecabet Sodium as an Adjuvant Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis. Helicobacter 2014; 19(5): 372 doi: 10.1111/hel.12136
|
| 16 |
Javier P. Gisbert, Javier Alcedo, Javier Amador, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Luis Fernández-Salazar, Emili Gené, Ángel Lanas, Alfredo Lucendo, Javier Molina-Infante, Olga P. Nyssen, A. Pérez-Aisa, Ignasi Puig. V Spanish Consensus Conference on Helicobacter pylori infection treatment. Gastroenterología y Hepatología (English Edition) 2022; 45(5): 392 doi: 10.1016/j.gastre.2021.07.001
|
| 17 |
Ping‐I Hsu, Feng‐Woei Tsay, John Y. Kao, Nan‐Jing Peng, Yan‐Hua Chen, Sheng‐Yeh Tang, Chao‐Hung Kuo, Sung‐Shuo Kao, Huay‐Min Wang, I‐Ting Wu, Chang‐Bih Shie, Seng‐Kee Chuah, Deng‐Chyang Wu. Tetracycline‐levofloxacin versus amoxicillin‐levofloxacin quadruple therapies in the second‐line treatment of Helicobacter pylori infection. Helicobacter 2021; 26(5) doi: 10.1111/hel.12840
|
| 18 |
Faezeh Kiani, Sara Khademolhosseini, Mobina Fathi, Arian Tavasol, Jasem Mohammadi, Majid Dousti, Jalal Eshagh Hoseini. Standard Triple Therapy as a Remedy for Treatment of Helicobacter pylori
Infection: A Systematic Review and Meta-analysis of Randomized Clinical
Trials. Current Reviews in Clinical and Experimental Pharmacology 2023; 18(2): 167 doi: 10.2174/2772432817666220317152544
|
| 19 |
Hong Lu, Wei Zhang, David Y. Graham. Bismuth-containing quadruple therapy for Helicobacter pylori. European Journal of Gastroenterology & Hepatology 2013; : 1 doi: 10.1097/MEG.0b013e3283633b57
|
| 20 |
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterología y Hepatología 2016; 39(10): 697 doi: 10.1016/j.gastrohep.2016.05.003
|
| 21 |
Hyun Jeong Lee, Jin Il Kim, Jin Soo Lee, Eun Jung Jun, Jung-Hwan Oh, Dae Young Cheung, Woo Chul Chung, Byung-Wook Kim, Sung Soo Kim. Concomitant therapy achieved the best eradication rate for <italic>Helicobacter pylori</italic> among various treatment strategies. World Journal of Gastroenterology 2015; 21(1): 351-359 doi: 10.3748/wjg.v21.i1.351
|
| 22 |
Li Feng, Mao-Yao Wen, Yong-Jun Zhu, Ruo-Ting Men, Li Yang. Sequential Therapy or Standard Triple Therapy for Helicobacter pylori Infection. American Journal of Therapeutics 2016; 23(3): e880 doi: 10.1097/MJT.0000000000000191
|
| 23 |
J. P. Gisbert, M. Romano, A. G. Gravina, P. Solís‐Muñoz, F. Bermejo, J. Molina‐Infante, M. Castro‐Fernández, J. Ortuño, A. J. Lucendo, M. Herranz, I. Modolell, F. del Castillo, J. Gómez, J. Barrio, B. Velayos, B. Gómez, J. L. Domínguez, A. Miranda, M. Martorano, A. Algaba, M. Pabón, T. Angueira, L. Fernández‐Salazar, A. Federico, A. C. Marín, A. G. McNicholl. Helicobacter pylori second‐line rescue therapy with levofloxacin‐ and bismuth‐containing quadruple therapy, after failure of standard triple or non‐bismuth quadruple treatments. Alimentary Pharmacology & Therapeutics 2015; 41(8): 768 doi: 10.1111/apt.13128
|
| 24 |
Yiyan Song, Jin Chen. Bismuth - Advanced Applications and Defects Characterization. 2018; doi: 10.5772/intechopen.75809
|
| 25 |
Fariborz Mansour-Ghanaei, Farahnaz Joukar, Mohammad Reza Naghipour, Atena Forouhari, Seyed Mohammad Seyed Saadat. Seven-day quintuple regimen as a rescue therapy for <italic>Helicobacter pylori</italic> eradication. World Journal of Gastroenterology 2015; 21(2): 661-666 doi: 10.3748/wjg.v21.i2.661
|
| 26 |
Luiz Gonzaga Coelho, Ismael Maguinilk, Schlioma Zaterka, José Miguel Parente, Maria do Carmo Friche Passos, Joaquim Prado P. Moraes-Filho. 3rd BRAZILIAN CONSENSUS ON Helicobacter pylori. Arquivos de Gastroenterologia 2013; 50(2): 81 doi: 10.1590/S0004-28032013005000001
|
| 27 |
Faezeh Kiani, Sara Khademolhosseini, Jasem Mohammadi, Arian Tavasol, Ramtin Hajibeygi, Mobina Fathi, Majid Dousti. Novel Information Regarding the Treatment of Helicobacter pylori Infection:
A Systematic Review and Meta-analysis of Randomized Clinical Trials. Current Reviews in Clinical and Experimental Pharmacology 2024; 19(2): 184 doi: 10.2174/2772432818666230120111237
|
| 28 |
Olga P. Nyssen, Belén Martínez, Francis Mégraud, Vincenzo Savarino, Carlo A. Fallone, Franco Bazzoli, Javier P. Gisbert. Sequential versus Standard Triple Therapy for First-Line Helicobacter pylori Eradication: An Update. Antibiotics 2024; 13(2): 136 doi: 10.3390/antibiotics13020136
|
| 29 |
Enrico Celestino Nista, Antonio Pellegrino, Lucia Giuli, Marcello Candelli, Tommaso Schepis, Sara Sofia De Lucia, Veronica Ojetti, Francesco Franceschi, Antonio Gasbarrini. Clinical Implications of Helicobacter pylori Antibiotic Resistance in Italy: A Review of the Literature. Antibiotics 2022; 11(10): 1452 doi: 10.3390/antibiotics11101452
|
| 30 |
Vikram Kate, Raja Kalayarasan, Nilakantan Ananthakrishnan. Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence. Drugs 2013; 73(8): 815 doi: 10.1007/s40265-013-0053-z
|
| 31 |
P Malfertheiner, F Megraud, C A O'Morain, J P Gisbert, E J Kuipers, A T Axon, F Bazzoli, A Gasbarrini, J Atherton, D Y Graham, R Hunt, P Moayyedi, T Rokkas, M Rugge, M Selgrad, S Suerbaum, K Sugano, E M El-Omar. Management ofHelicobacter pyloriinfection—the Maastricht V/Florence Consensus Report. Gut 2017; 66(1): 6 doi: 10.1136/gutjnl-2016-312288
|
| 32 |
Xiuhong Yang, Pengsheng Tan, Lianying Song, Zhanying Lu. Comparison Between Sequential Therapy and Modified Bismuth-Included Quadruple Therapy for Helicobacter pylori Eradication in Chinese Patients. American Journal of Therapeutics 2016; 23(6): e1436 doi: 10.1097/MJT.0000000000000261
|
| 33 |
Hyuk Yoon, Dong Ho Lee, Nayoung Kim, Young Soo Park, Cheol Min Shin, Kyu Keun Kang, Dong Hyun Oh, Dong Kee Jang, Jun‐Won Chung. Meta‐analysis: Is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?. Journal of Gastroenterology and Hepatology 2013; 28(12): 1801 doi: 10.1111/jgh.12397
|
| 34 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(4): 261 doi: 10.7704/kjhugr.2020.0045
|
| 35 |
Joon Sung Kim, Jeong-Seon Ji, Hwang Choi, Joo Hyun Kim. Sequential therapy or triple therapy for Helicobacter pylori infection in Asians: Systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2014; 38(1): 118 doi: 10.1016/j.clinre.2013.10.001
|
| 36 |
Javier P. Gisbert, Javier Molina-Infante, Javier Amador, Fernando Bermejo, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Antonio Cuadrado-Lavín, J. Ignasi Elizalde, Emili Gene, Fernando Gomollón, Ángel Lanas, Carlos Martín de Argila, Fermín Mearin, Miguel Montoro, Ángeles Pérez-Aisa, Emilio Pérez-Trallero, Adrián G. McNicholl. IV Spanish Consensus Conference on Helicobacter pylori infection treatment. Gastroenterología y Hepatología (English Edition) 2016; 39(10): 697 doi: 10.1016/j.gastre.2016.11.007
|
| 37 |
|
| 38 |
Oguzhan Ozturk, Levent Doganay, Yasar Colak, Feruze Yilmaz Enc, Celal Ulasoglu, Kamil Ozdil, Ilyas Tuncer. Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication. Arab Journal of Gastroenterology 2017; 18(2): 62 doi: 10.1016/j.ajg.2017.05.002
|
| 39 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition. The Korean Journal of Medicine 2021; 96(3): 160 doi: 10.3904/kjm.2021.96.3.160
|
| 40 |
Varocha Mahachai, Nathavut Sirimontaporn, Somying Tumwasorn, Duangporn Thong‐Ngam, Ratha‐Korn Vilaichone. Sequential therapy in clarithromycin‐sensitive and ‐resistant Helicobacter pylori based on polymerase chain reaction molecular test. Journal of Gastroenterology and Hepatology 2011; 26(5): 825 doi: 10.1111/j.1440-1746.2011.06660.x
|
| 41 |
Jing Li, Huiying Shi, Fang Zhou, Li Xie, Rong Lin. The Efficacy and Safety of Regimens for Helicobacter pylori Eradication Treatment in China. Journal of Clinical Gastroenterology 2024; 58(1): 12 doi: 10.1097/MCG.0000000000001902
|
| 42 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence-Based Guidelines for the Treatment of <i>Helicobacter pylori</i> Infection in Korea 2020. Gut and Liver 2021; 15(2): 168 doi: 10.5009/gnl20288
|
| 43 |
Yang Yang, Ruizhuo Ouyang, Lina Xu, Ning Guo, Weiwei Li, Kai Feng, Lei Ouyang, Zhuoyuan Yang, Shuang Zhou, Yuqing Miao. Review: Bismuth complexes: synthesis and applications in biomedicine. Journal of Coordination Chemistry 2015; 68(3): 379 doi: 10.1080/00958972.2014.999672
|
| 44 |
Sarah Gurney, Laura Carvalho, Carrie Gonzalez, Esperanza Galaviz, Frances Sonstein. An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori. The Journal for Nurse Practitioners 2014; 10(1): 22 doi: 10.1016/j.nurpra.2013.09.013
|
| 45 |
Ben Wang, Zhi-Fa Lv, You-Hua Wang, Hui Wang, Xiao-Qun Liu, Yong Xie, Xiao-Jiang Zhou. Standard triple therapy for <italic>Helicobacter pylori</italic> infection in China: A meta-analysis. World Journal of Gastroenterology 2014; 20(40): 14973-14985 doi: 10.3748/wjg.v20.i40.14973
|
| 46 |
Seyed Hossein Hoseinifar, Mohammad Amin Jahazi, Roghieh Mohseni, Morteza Yousefi, Mahsan Bayani, Mohammad Mazandarani, Hien Van Doan, Ehab R. El-Haroun. Dietary apple peel-derived pectin improved growth performance, antioxidant enzymes and immune response in common carp, Cyprinus carpio (Linnaeus, 1758). Aquaculture 2021; 535: 736311 doi: 10.1016/j.aquaculture.2020.736311
|
| 47 |
Ummay Mahfuza Shapla, Jinat Raihan, Asiful Islam, Fahmida Alam, Naeem Solayman, Siew Hua Gan, Sakib Hossen, Ibrahim Khalil. Propolis: The future therapy against Helicobacter pylori-mediated gastrointestinal diseases. Journal of Applied Biomedicine 2018; 16(2): 81 doi: 10.1016/j.jab.2017.10.007
|
| 48 |
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi. Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020. The Korean Journal of Internal Medicine 2021; 36(4): 807 doi: 10.3904/kjim.2020.701
|
| 49 |
Javier P. Gisbert, Javier Alcedo, Javier Amador, Luis Bujanda, Xavier Calvet, Manuel Castro-Fernández, Luis Fernández-Salazar, Emili Gené, Ángel Lanas, Alfredo J. Lucendo, Javier Molina-Infante, Olga P. Nyssen, A. Pérez-Aisa, Ignasi Puig. V Conferencia Española de Consenso sobre el tratamiento de la infección por Helicobacter pylori. Gastroenterología y Hepatología 2022; 45(5): 392 doi: 10.1016/j.gastrohep.2021.07.011
|
| 50 |
Angelo Zullo, Cesare Hassan, Lorenzo Ridola, Vincenzo De Francesco, Dino Vaira. Standard triple and sequential therapies for Helicobacter pylori eradication: An update. European Journal of Internal Medicine 2013; 24(1): 16 doi: 10.1016/j.ejim.2012.07.006
|
| 51 |
Zhiqiang Song, Liya Zhou, Jianzhong Zhang, Lihua He, Peng Bai, Yan Xue. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy. Digestive and Liver Disease 2016; 48(5): 506 doi: 10.1016/j.dld.2016.01.002
|